What are extrapyramidal symptoms (EPS) and which drug class often causes them?

Prepare for the ECPI Mental Health Exam. Study with comprehensive quizzes, detailed explanations, and helpful hints. Equip yourself with the knowledge and confidence needed to succeed on your exam journey!

Multiple Choice

What are extrapyramidal symptoms (EPS) and which drug class often causes them?

Explanation:
Extrapyramidal symptoms are drug-induced movement disorders caused by strong blockade of dopamine D2 receptors in the nigrostriatal pathway. They present as a range of motor effects: acute dystonia (sustained muscle contractions), akathisia (inner restlessness), parkinsonism (tremor, rigidity, slowed movements), and tardive dyskinesia (involuntary movements, often after long-term use). The drugs most likely to cause these are typical (first-generation) antipsychotics, which strongly block D2 receptors and thus disrupt dopaminergic signaling in motor circuits. Atypical antipsychotics have a lower but still possible risk, especially at higher doses. The other options don’t fit EPS because digestive issues, seizures, and allergic reactions involve different biological mechanisms and do not reflect the characteristic motor syndromes produced by nigrostriatal dopamine blockade.

Extrapyramidal symptoms are drug-induced movement disorders caused by strong blockade of dopamine D2 receptors in the nigrostriatal pathway. They present as a range of motor effects: acute dystonia (sustained muscle contractions), akathisia (inner restlessness), parkinsonism (tremor, rigidity, slowed movements), and tardive dyskinesia (involuntary movements, often after long-term use). The drugs most likely to cause these are typical (first-generation) antipsychotics, which strongly block D2 receptors and thus disrupt dopaminergic signaling in motor circuits. Atypical antipsychotics have a lower but still possible risk, especially at higher doses. The other options don’t fit EPS because digestive issues, seizures, and allergic reactions involve different biological mechanisms and do not reflect the characteristic motor syndromes produced by nigrostriatal dopamine blockade.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy